Changes in number of peripheral blood cells in patients with chronic hepatitis C after treated with interferon alpha 2b combined with ribavirin and their clinical significances

Linyuan MA,Peng ZHANG,Qian CHEN,Wenli KONG,Yiliang YANG,Yuxiang LI,Yu PAN

DOI: https://doi.org/10.13481/j.1671-587x.20150332

2015-01-01

Abstract:Objective To explore the changes in the number of peripheral blood cells in the patients with chronic hepatitis C(CHC)after treated with interferon alpha 2b(IFN-α2b)combined with ribavirin,and to clarify the impact factors of the number of peripheral blood cells.Methods A total of 343 CHC patients with symptoms of chronic hepatitis and positive anti-HCV and HCV RNA were selected. All patients received IFN-α2b(5 000 000 U,every other day,subcutaneous)combined with ribavirin(15mg·kg-1·d-1,oral)for 48 weeks.The number of peripheral blood cells and serum HCV RNA level were assessed at 12,24,36,48,60,72,and96 weeks.The patients who developed neutropenia,anemia and thrombocytopenia would be treated according to2010Hepatitis C Treatment Guidelines.Results The prevalence of neutropenia,anemia and thrombocytopenia were 40.5%(139),48.4%(166)and 39.9%(137),respectively.There were changes in the number of peripheral blood cells of individual patients after treatment.The most of changes occured from the beginning to12 weeks.The number of neutrophils,hemoglobin and plateletsin were significantly decreased in 2weeks,while the minimum value appeared at the 12 th weeks followed by a slow rise.At the end of treatment(48 weeks),although the recovery was obvious,but not yet reached the pre-treatment levels.They recoved to the pre-treatment levels at 60 to 72 weeks.The baseline of absolute neutrophil count(ANC),plateletsin(PLT),aspartate transaminase(AST),alanine transaminase(ALT)and liver fibrosis were associated with neutropenia(P0.05).The gender and baseline of hemoglobin levels were related to anemia(P0.05).Gender,baseline of ANC,PLT,AST,ALT,γ-glutamyl transferase(γ-GT)and liver fibrosis were associated with thrombocytopenia(P0.05).Conclusion The number of peripheral blood cells is significantly decreased in 2weeks after anti-virus therapy,and reaches a minimum at 12 weeks,which reminds that clinicians should perform intervention and follow up timely to avoid serious adverse events.The occurrence and severity of reduction in the number of peripheral blood cells could be assessed according to the baseline gender,level of peripheral blood cells,liver function and liver fibrosis.